Sign in
ORYZF Stock Price, Chart, Stats & News
Oryzon Genomics S.A.
Save
Oryzon Genomics S.A. (ORYZF) does not currently pay a dividend.
271.28M
Market cap
–
Current P/E
19.68x
Forward P/E
ORYZF chart
About
Health care
Sector
Biotechnology
Industry
Oryzon Genomics S. A. is a clinical-stage biopharmaceutical company dedicated to advancing epigenetics-based therapies for individuals battling cancer and central nervous system (CNS) conditions. The company's clinical pipeline features two key compounds.
Similar securities
Based on sector and market capitalization
Report issue